Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout

PHASE2CompletedINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Joint Damage
Interventions
DRUG

Febuxostat

Febuxostat capsules

DRUG

Placebo for Febuxostat

Febuxostat placebo-matching capsules

Trial Locations (56)

Unknown

Mesa

Tucson

Burbank

Carmichael

Costa Mesa

Irvine

Orange

Rancho Cucamonga

San Diego

San Luis Obispo

Trumbull

Boynton Beach

Daytona Beach

Fort Lauderdale

Hialeah

Miami

Sanford

Tampa

Winter Park

Honolulu

Arlington Heights

Avon

Greenfield

Wichita

Rockport

Chaska

Belzoni

Olive Branch

Billings

Missoula

Bellevue

Henderson

Las Vegas

Albuquerque

Charlotte

Lenoir

Shelby

Dayton

Franklin

Willoughby Hills

Oklahoma City

Eugene

Duncansville

East Providence

Columbia

Rapid City

Kingsport

Austin

Houston

San Antonio

Southlake

Sugar Land

Arlington

Burke

Manassas

Kenosha

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01078389 - Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout | Biotech Hunter | Biotech Hunter